Antibiotics Currently in Global Clinical Development

As of June 2019, approximately 42 new antibiotics with the potential to treat serious bacterial infections are in clinical development. The success rate for clinical drug development is low; historical data show that, generally, only 1 in 5 infectious disease products that enter human testing (phase 1 clinical trials) will be approved for patients. The article shows a snapshot of the current antibiotic pipeline, based on publicly available information and informed by external experts.

Smart Innovations   Back